Takeda teams with Sanford-Burnham on cardio R&D; Medicines Co. touts early promise for sedative;

@FierceBiotech: ASCO 15: The top 10 setbacks, advances and head scratchers. Editor's corner | Follow @FierceBiotech

@JohnCFierce: $IMGN shares up 14% on positive early data for ovarian cancer ADC. Release | Follow @JohnCFierce

> Takeda has partnered up with the Sanford-Burnham Medical Research Institute to study how certain regulatory proteins relate to heart failure. Under a two-year collaboration, the pair aims to discover small-molecule treatments that strengthen the heart. More

> ABP-700, a new short-acting sedative from the Medicines Company ($MDCO), came through in a Phase I trial. News

> Puma Biotechnology's ($PBYI) breast cancer drug helped women already treated with Herceptin stay free of invasive disease in a Phase III trial, but the drug only narrowly bested placebo. More

Medical Device News

@FierceMedDev: ICYMI: DOJ slaps Olympus with a subpoena over dirty duodenoscopes. Article | Follow @FierceMedDev

@VarunSaxena2: FMD exclusive (got insider tip): Zimmer to cut some staff as it barrels toward merger with Biomet. Story | Follow @VarunSaxena2

@EmilyWFierce: ICYMI from FiercePharma: Otsuka faces the music for generic Abilify, loses battle with FDA. Article | Follow @EmilyWFierce

> Molecular Dx: Invitae drops prices as NIH starts 1,000-patient, molecular abnormalities cancer study. More

> Startup Arsenal Medical and its spinoff raise $26.5M to develop novel foam, nanofiber and bioresorbable products. Article

Pharma News

@FiercePharma: ICYMI: Adding Opdivo to Yervoy ups melanoma treatment efficacy--but it ups rate of serious side effects, too. Report | Follow @FiercePharma

@CarlyHFierce: UPDATED w/Genentech comment: Roche's Gazyva doubles remission time for non-Hodgkin lymphoma patients. Story | Follow @CarlyHFierce

> Top oncologist joins chorus of pricing critics in high-profile ASCO speech. More

> UCB reportedly gets bids for Kremers Urban unit from Cipla and Lupin. Article

Animal Health News

> Tech makers market health wearables to dog owners. Item

> Groundbreaking held for the new $1.2B NABF animal health facility in Kansas. More

> Bayer CEO Dekkers looking 'with interest' at animal-health additions. Report

> K-State researchers build avian-flu protection into existing poultry vaccine. Article

> Novozymes enters booming market for poultry probiotics. Story

Biotech IT News

> CRISPR Therapeutics starts search for a bioinformatics chief. More

> Bioinformatics leads UCSD team to ovarian cancer biomarkers. Story

> AstraZeneca's Definiens rolls out biomarker data service. Item

> Artificial intelligence tops Google VC's list of high-potential life sci techs. Article

> UT Southwestern snags $5.6M grant to boost bioinformatics operation. Report

Pharma Marketing News

> Stars of cancer meeting set to crack top 10 cancer sales by 2020. Article

> Valeant plots big DTC push for Xifaxan while rival Actavis drug waits on DEA. Report

> Novartis rolls out 'life hacks' for MS patients with new Live Like You campaign. Article

> ASCO must-reads: Pfizer's Ibrance; BMS, Novartis melanoma meds; J&J's Imbruvica and more. More

> Abbott takes Pedialyte on the festival circuit as grown-up hangover remedy. Story

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

City of Hope and Canadian biotech Biovaxys Technology reported positive animal data for their COVID vaccines that could offer alternatives to mRNA.

4D is adding a trio of executives to spearhead its work in heart, eye and lung diseases as it pushes programs into and through the clinic.

Janssen has sent off its mutation-specific non-small cell lung cancer drug amivantamab to the FDA.